Net Issuance Of Debt - CASI Pharmaceuticals Inc (NASDAQ:CASI) - Alpha Spread
C

CASI Pharmaceuticals Inc
NASDAQ:CASI

Watchlist Manager
CASI Pharmaceuticals Inc
NASDAQ:CASI
Watchlist
Price: 6.54 USD -3.25% Market Closed
Market Cap: 87.6m USD
Have any thoughts about
CASI Pharmaceuticals Inc?
Write Note

CASI Pharmaceuticals Inc
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CASI Pharmaceuticals Inc
Net Issuance of Debt Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
C
CASI Pharmaceuticals Inc
NASDAQ:CASI
Net Issuance of Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Issuance of Debt
$9.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Net Issuance of Debt
-$2.1B
CAGR 3-Years
N/A
CAGR 5-Years
7%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Issuance of Debt
$1.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-18%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Issuance of Debt
-$48.4m
CAGR 3-Years
-25%
CAGR 5-Years
-13%
CAGR 10-Years
2%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Issuance of Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is CASI Pharmaceuticals Inc's Net Issuance of Debt?
Net Issuance of Debt
0 USD

Based on the financial report for Dec 31, 2023, CASI Pharmaceuticals Inc's Net Issuance of Debt amounts to 0 USD.

Back to Top